NetworkNewsBreaks – FinCanna Capital Corp. (CSE:
Post# of 30
(Total Views: 226)
Posted On: 07/12/2018 7:00:04 PM
NetworkNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investment Executes Manufacturing and Distribution Agreement with Phoenix Tears LLC
FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning announced that Cultivation Technologies Inc. (“CTI”), its first investment in California, has executed an agreement with Phoenix Tears LLC to be the exclusive manufacturer and distributer of official Phoenix Tears THC-based products in California. Per the update, Phoenix Tears has supported more than 200,000 individuals through its cannabis brands and products since its inception in 2010. “This agreement represents a significant step forward for CTI as they continue to build out their manufacturing, distribution and marketing businesses of cannabis and cannabis-related products,” Andriyko Herchak, president and CEO of FinCanna Capital, stated in the news release. “This agreement continues to validate our investment in CTI, and gives our shareholders growing access to the burgeoning medical cannabis market in California.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning announced that Cultivation Technologies Inc. (“CTI”), its first investment in California, has executed an agreement with Phoenix Tears LLC to be the exclusive manufacturer and distributer of official Phoenix Tears THC-based products in California. Per the update, Phoenix Tears has supported more than 200,000 individuals through its cannabis brands and products since its inception in 2010. “This agreement represents a significant step forward for CTI as they continue to build out their manufacturing, distribution and marketing businesses of cannabis and cannabis-related products,” Andriyko Herchak, president and CEO of FinCanna Capital, stated in the news release. “This agreement continues to validate our investment in CTI, and gives our shareholders growing access to the burgeoning medical cannabis market in California.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)